BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 35830870)

  • 1. De novo molecular design with deep molecular generative models for PPI inhibitors.
    Wang J; Chu Y; Mao J; Jeon HN; Jin H; Zeb A; Jang Y; Cho KH; Song T; No KT
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35830870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Explore drug-like space with deep generative models.
    Wang J; Mao J; Wang M; Le X; Wang Y
    Methods; 2023 Feb; 210():52-59. PubMed ID: 36682423
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhang J; Chen H
    J Chem Inf Model; 2022 Jul; 62(14):3291-3306. PubMed ID: 35793555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generative Deep Learning for Targeted Compound Design.
    Sousa T; Correia J; Pereira V; Rocha M
    J Chem Inf Model; 2021 Nov; 61(11):5343-5361. PubMed ID: 34699719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De Novo Peptide and Protein Design Using Generative Adversarial Networks: An Update.
    Lin E; Lin CH; Lane HY
    J Chem Inf Model; 2022 Feb; 62(4):761-774. PubMed ID: 35128926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based
    Li Y; Pei J; Lai L
    Chem Sci; 2021 Oct; 12(41):13664-13675. PubMed ID: 34760151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Algorithm-Based Receptor Ligand: A Genetic Algorithm-Guided Generative Model to Boost the Novelty and Drug-Likeness of Molecules in a Sampling Chemical Space.
    Wang M; Wu Z; Wang J; Weng G; Kang Y; Pan P; Li D; Deng Y; Yao X; Bing Z; Hsieh CY; Hou T
    J Chem Inf Model; 2024 Feb; 64(4):1213-1228. PubMed ID: 38302422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNMG: Deep molecular generative model by fusion of 3D information for de novo drug design.
    Song T; Ren Y; Wang S; Han P; Wang L; Li X; Rodriguez-Patón A
    Methods; 2023 Mar; 211():10-22. PubMed ID: 36764588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Estimate Index for Early-Stage Screening of Compounds Targeting Protein-Protein Interactions.
    Kosugi T; Ohue M
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep Learning Applied to Ligand-Based De Novo Drug Design.
    Palazzesi F; Pozzan A
    Methods Mol Biol; 2022; 2390():273-299. PubMed ID: 34731474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A de novo molecular generation method using latent vector based generative adversarial network.
    Prykhodko O; Johansson SV; Kotsias PC; Arús-Pous J; Bjerrum EJ; Engkvist O; Chen H
    J Cheminform; 2019 Dec; 11(1):74. PubMed ID: 33430938
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Atance SR; Diez JV; Engkvist O; Olsson S; Mercado R
    J Chem Inf Model; 2022 Oct; 62(20):4863-4872. PubMed ID: 36219571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generative Adversarial Networks for De Novo Molecular Design.
    Lee YJ; Kahng H; Kim SB
    Mol Inform; 2021 Oct; 40(10):e2100045. PubMed ID: 34622551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo generation of dual-target ligands using adversarial training and reinforcement learning.
    Lu F; Li M; Min X; Li C; Zeng X
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design.
    Skalic M; Sabbadin D; Sattarov B; Sciabola S; De Fabritiis G
    Mol Pharm; 2019 Oct; 16(10):4282-4291. PubMed ID: 31437001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances and Challenges in De Novo Drug Design Using Three-Dimensional Deep Generative Models.
    Xie W; Wang F; Li Y; Lai L; Pei J
    J Chem Inf Model; 2022 May; 62(10):2269-2279. PubMed ID: 35544331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graph-based generative models for de Novo drug design.
    Xia X; Hu J; Wang Y; Zhang L; Liu Z
    Drug Discov Today Technol; 2019 Dec; 32-33():45-53. PubMed ID: 33386094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep learning for molecular generation.
    Xu Y; Lin K; Wang S; Wang L; Cai C; Song C; Lai L; Pei J
    Future Med Chem; 2019 Mar; 11(6):567-597. PubMed ID: 30698019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo drug design by iterative multiobjective deep reinforcement learning with graph-based molecular quality assessment.
    Fang Y; Pan X; Shen HB
    Bioinformatics; 2023 Apr; 39(4):. PubMed ID: 36961341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-objective de novo drug design with conditional graph generative model.
    Li Y; Zhang L; Liu Z
    J Cheminform; 2018 Jul; 10(1):33. PubMed ID: 30043127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.